Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trial

Shao Y.-F.Yang J.-M.Chau G.-Y.Sirivatanauksorn Y.Zhong S.-X.Erhardtsen E.Nivatvongs S.PO-HUANG LEE2020-11-192020-11-1920060002-9610https://www.scopus.com/inward/record.uri?eid=2-s2.0-31444433052&doi=10.1016%2fj.amjsurg.2005.10.019&partnerID=40&md5=a9ee6c73b296fd4021f46cb2b7ddfbebhttps://scholars.lib.ntu.edu.tw/handle/123456789/521442[SDGs]SDG3Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trialjournal article10.1016/j.amjsurg.2005.10.019164429542-s2.0-31444433052